ForumIAS LATEST
- SFG FRC 2027 | Program starts from 19th Dec. 2026 | Admissions open for Entrance Test Click Here to know more →
- Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
- [Pre-order] Ethics Redbook 3rd Edition: Delivery starts from 10th October onwards Click Here to Read More →
- 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 11th Oct. Click Here to Read More →
News: Bhabha Atomic Research Centre(BARC) Mumbai has developed an Eye Cancer therapy. It was the first indigenous Ruthenium 106 Plaque for the treatment of Ocular Tumors.
Facts:
- Ruthenium-106: It is a radioactive form of the rare heavy metal ruthenium. It is a “platinum group” metal similar to platinum.
- How is it produced? It is produced from the fission or splitting of uranium-235, the type of uranium used in nuclear fission reactors, so it’s found in spent nuclear fuel.
- Uses: It is used in medicine for cancer radiation therapy, especially for eye and skin tumors. It is also used in radioisotope thermoelectric generators that power satellites.
- Harmful to Humans: High doses of ruthenium are toxic and carcinogenic when ingested. The material is strongly retained in the bones.
